First Innovative Antimalarial of Artemisinin Based Combination Therapy (ACT)

Artemether and lumefantrine tablets is the first generation of Artemisinin based combination therapy (ACT) antimalarial agent which initially developed by cooperation of KPC and China Academy of Military Medical Science (AMMS) and later partially transferred to Swiss Novartis AG. Coartem has brought hope and revolutionary progress to the world in the treatment of malaria and has now recognized world wide. Comether is the product soley manufactured and marketed by KPC.